Clinical value of the sentinel-node biopsy in primary cutaneous melanoma

Affiliations

¹ From the University of Texas Southwestern Medical Center, Dallas (C.M.B.); and the Department of Surgical Oncology, Melanoma and Skin Center, University of Texas M.D. Anderson Cancer Center, Houston (J.E.G.).

Editorial

Charles M Balch et al. N Engl J Med. 2014.

. 2014 Feb 13;370(7):663-4.

doi: 10.1056/NEJMe1313690.

¹ From the University of Texas Southwestern Medical Center, Dallas (C.M.B.); and the Department of Surgical Oncology, Melanoma and Skin Center, University of Texas M.D. Anderson Cancer Center, Houston (J.E.G.).

No abstract available

Comment on

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.
Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang HJ, Elashoff R, Faries MB; MSLT Group. Morton DL, et al. N Engl J Med. 2014 Feb 13;370(7):599-609. doi: 10.1056/NEJMoa1310460. N Engl J Med. 2014. PMID: 24521106 Free PMC article. Clinical Trial.